Related references
Note: Only part of the references are listed.Is Visible Aminolevulinic Acid-Induced Fluorescence an Independent Biomarker for Prognosis in Histologically Confirmed (World Health Organization 2016) Low-Grade Gliomas?
Mohammed Jaber et al.
NEUROSURGERY (2019)
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0
Ian Law et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Conscious sedation with dexmedetomidine compared with asleep-awake-asleep craniotomies in glioma surgery: an analysis of 180 patients
Eric Suero Molina et al.
JOURNAL OF NEUROSURGERY (2018)
Extent of resection of peritumoral diffusion tensor imaging-detected abnormality as a predictor of survival in adult glioblastoma patients
Jiun-Lin Yan et al.
JOURNAL OF NEUROSURGERY (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1)
Oliver Oehlke et al.
BMC CANCER (2016)
The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
Yan Michael Li et al.
JOURNAL OF NEUROSURGERY (2016)
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas
Nathalie L. Albert et al.
NEURO-ONCOLOGY (2016)
Combining 5-Aminolevulinic Acid Fluorescence and Intraoperative Magnetic Resonance Imaging in Glioblastoma Surgery: A Histology-Based Evaluation
Sonja B. Hauser et al.
NEUROSURGERY (2016)
The Value of 5-Aminolevulinic Acid in Low-grade Gliomas and High-grade Gliomas Lacking Glioblastoma Imaging Features: An Analysis Based on Fluorescence, Magnetic Resonance Imaging, 18F-Fluoroethyl Tyrosine Positron Emission Tomography, and Tumor Molecular Factors
Mohammed Jaber et al.
NEUROSURGERY (2016)
18F-Fluoroethyl-L-Thyrosine Positron Emission Tomography to Delineate Tumor Residuals After Glioblastoma Resection: A Comparison with Standard Postoperative Magnetic Resonance Imaging
Niels Buchmann et al.
WORLD NEUROSURGERY (2016)
Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM
Bogdana Suchorska et al.
NEUROLOGY (2015)
5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma
Philippe Schucht et al.
ACTA NEUROCHIRURGICA (2014)
5-Aminolevulinic Acid-derived Tumor Fluorescence: The Diagnostic Accuracy of Visible Fluorescence Qualities as Corroborated by Spectrometry and Histology and Postoperative Imaging
Walter Stummer et al.
NEUROSURGERY (2014)
Is Supratotal Resection of Glioblastoma in Noneloquent Areas Possible?
Hugues Duffau
WORLD NEUROSURGERY (2014)
Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy
F. -W. Kreth et al.
ANNALS OF ONCOLOGY (2013)
Prognostic Value of Residual Fluorescent Tissue in Glioblastoma Patients After Gross Total Resection in 5-Aminolevulinic Acid-Guided Surgery
Guillermo Aldave et al.
NEUROSURGERY (2013)
Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery
Walter Stummer et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Application of Novel Response/Progression Measures for Surgically Delivered Therapies for Gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group
Michael A. Vogelbaum et al.
NEUROSURGERY (2012)
Gross Total Resection Rates in Contemporary Glioblastoma Surgery: Results of an Institutional Protocol Combining 5-Aminolevulinic Acid Intraoperative Fluorescence Imaging and Brain Mapping
Philippe Schucht et al.
NEUROSURGERY (2012)
Comparison of 18F-FET PET and 5-ALA fluorescence in cerebral gliomas
Frank Willi Floeth et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study Clinical article
Walter Stummer et al.
JOURNAL OF NEUROSURGERY (2011)
Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters Clinical article
David W. Roberts et al.
JOURNAL OF NEUROSURGERY (2011)
An extent of resection threshold for newly diagnosed glioblastomas
Nader Sanai et al.
JOURNAL OF NEUROSURGERY (2011)
Pathological characterization of the glioblastoma border as shown during surgery using 5-aminolevulinic acid-induced fluorescence
Miguel Angel Idoate et al.
NEUROPATHOLOGY (2011)
Prognostic impact of postoperative, pre-irradiation 18F-fluoroethyl-L-tyrosine uptake in glioblastoma patients treated with radiochemotherapy
Marc D. Piroth et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Association of F18-fluoro-ethyl-tyrosin uptake and 5-aminolevulinic acid-induced fluorescence in gliomas
Florian Stockhammer et al.
ACTA NEUROCHIRURGICA (2009)
Independent association of extent of resection with survival in patients with malignant brain astrocytoma
Matthew J. McGirt et al.
JOURNAL OF NEUROSURGERY (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
et al.
NEUROSURGERY (2009)
ASSOCIATION OF SURGICALLY ACQUIRED MOTOR AND LANGUAGE DEFICITS ON OVERALL SURVIVAL AFTER RESECTION OF GLIOBLASTOMA MULTIFORME
Matthew J. McGirt et al.
NEUROSURGERY (2009)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
Erik von Elm et al.
LANCET (2007)
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
W Stummer et al.
LANCET ONCOLOGY (2006)
O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas
D Pauleit et al.
BRAIN (2005)
Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients
W Stummer et al.
JOURNAL OF NEUROSURGERY (2000)
Time-dependent ROC curves for censored survival data and a diagnostic marker
PJ Heagerty et al.
BIOMETRICS (2000)
Share Paper
